This post has been archived and contains information that may be out of date.
In a May 3 letter to CHA, UnitedHealthcare (UHC) announced it will temporarily suspend implementation of its new sepsis review policy in California until Nov. 1. The delay — a result of CHA’s advocacy on the issue — is intended to allow additional time to work through administrative and other issues that are unique to the California market, in particular due to California hospitals’ prevalent use of full-risk, capitated, delegated network arrangements.
This content is restricted to members.
